Analysis of three publications including 372 patients showed no significant difference in the overall incidence of hypertension between individuals administered SYK and/or BTK inhibitors and those given a placebo (RR 1.38; 95%CI: 0.82 – 2.32, p=0.23, I2 = 0%, random-effect model). Here, SYK is linked to Hypertension.